About: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: $6.31 (-1.71%)
AVR NASDAQ Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp. Common Stock share price
Atividade de preço de AVR
Último preço
$ 6,310
Variação (24h)
-0,11 USD (1,71%)
Volume
1.40M
Volume (média 4 sem.)
-
Abertura
$ 6,33
Variação do dia
$ 6,11 - $ 6,37
Fechamento anterior
$ 6,42
Último negócio
30 Oct, 8:00 pm GMT+0
Atrasado
30 Oct, 8:00 pm GMT+0
AVR price performance
Atrasado
30 Oct, 8:00 pm GMT+0
quote.marketSignals